With the P1a dosing regime and focus on safety, and not optimal dosing it has me questioning how much cpacs/mopacs data we will get. There is no doubt Bis is an anti cancer drug. This will not move the dial. Sorry should've worded my Q better- Do we have to wait until P1b to get the juice that will awaken the market via CPAcs in human validation?
Thank you @Dprent
No e the less. Dosing someone end of June is not good enough
- Forums
- ASX - By Stock
- RAC
- Ann: March 2025 Quarterly Activity Report and Appendix 4C
RAC
race oncology ltd
Add to My Watchlist
3.38%
!
$1.15

Ann: March 2025 Quarterly Activity Report and Appendix 4C, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
-0.040(3.38%) |
Mkt cap ! $198.9M |
Open | High | Low | Value | Volume |
$1.22 | $1.22 | $1.13 | $132.0K | 114.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2390 | $1.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 4805 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2390 | 1.140 |
3 | 5274 | 1.135 |
4 | 7220 | 1.130 |
1 | 2008 | 1.125 |
5 | 14965 | 1.120 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 4805 | 1 |
1.205 | 2500 | 1 |
1.220 | 21445 | 4 |
1.230 | 7500 | 2 |
1.245 | 2000 | 1 |
Last trade - 15.57pm 04/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online